Anagnostics | GenomeWeb

Anagnostics

Anagnostics aims to include the marker in a new version of its Hybcell Inflammation integrated sepsis monitoring test.

The researchers are also developing the method in tandem with a more extensive pathogen profiling diagnostic platform from Swedish startup Q-linea.

NEW YORK (GenomeWeb) – Austrian molecular diagnostics firm Anagnostics recently launched a new assay designed to detect sepsis-associated bacteria and fungi using a single array.

Anagnostics is planning to expand its sales and marketing activities in the EU as well as the US as it narrows its focus to its nascent integrated sepsis diagnostics business.

Austrian molecular diagnostics firm Anagnostics said this week that it has received CE-IVD approval for two tests based on its Hybcell cylindrical microarray platform.

Austrian molecular diagnostics firm Anagnostics said this week that it is now using Scienion's SciFlexarrayer to produce its cylindrical Hybcell arrays.

NEW YORK (GenomeWeb News) – Scienion and Anagnostics Bioanalysis today said that Anagnostics is using Scienion's SciFlexArrayer in the production of Anagnostics' new products focused on integrating sepsis testing.

Austrian array company Anagnostics recently achieved a CE-IVD mark for a test that could help clinicians guide treatment for patients with sepsis. Separately, the firm announced a new distribution partnership in Belgium, further expanding its presence in Europe.

Nanosphere has appointed Roy Davis to its board of directors.

This story has been updated to include comments from company executives.
Austrian array company Anagnostics Bioanalysis recently announced a deal with Molzym to develop and launch a test for sepsis.

Pages

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.